Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (945)	6/7/1999 8:07:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 965

Sort of a clear opinion. Thanks. Peter...... this sounds like something that you (or someone else perhaps, so apologies in advance) might have suggested as a munchee...... Monday June 7, 4:02 pm Eastern Time Company Press Release Creative BioMolecules, Inc. Announces Stryker's Submission of OP-1 Implant for Approval in the United States and Europe BOSTON--(BW HealthWire)--June 7, 1999--Creative BioMolecules, Inc. (Nasdaq:CBMI - news) announced today that Stryker Corp. (NYSE:SYK - news), its partner in orthopaedic and dental reconstruction, has submitted applications in both the United States and Europe seeking marketing approval for the OP-1 bone graft device, also known as the OP-1 Implant(TM). (snip)